Objectives: Wide variation in practice continues to exist regarding the necessity of revascularization of the left subclavian artery among patients who undergo elective thoracic endovascular aortic repair (TEVAR) with coverage of the left subclavian artery. This study aims to analyze the outcomes of TEVAR with concomitant carotid-subclavian bypass versus TEVAR alone among patients whose left subclavian artery is covered.
Methods: A retrospective analysis of prospectively collected data was performed using the National Surgical Quality Improvement Program for patients undergoing nonemergent TEVAR with coverage of the left subclavian artery from 2012 to 2016. Demographics, comorbidities, and 30-day outcomes were compared among patients who underwent TEVAR with and without concomitant carotid subclavian bypass. Multivariable analysis was used to adjust for differences in demographic and operative characteristics.
Results: A total of 603 patients underwent nonemergent TEVAR with coverage of the left subclavian artery: 130 with concomitant carotid-subclavian bypass and 473 without. Other than a slightly older population in the group without a bypass (68 years vs 66 years; P ¼ .047), there were no significant differences in baseline demographics or comorbidities between the two groups. Patients with concomitant carotid-subclavian bypass had a significantly higher risk of stroke (7.7% vs 2.8%; P < .01), Objectives: Endovascular treatment of juxtarenal and thoracoabdominal aortic aneurysms continues to evolve with increasing use of fenestrated, branched, and parallel graft techniques. The lack of flexibility of the current distal balloon expandable stent has been implicated in acute and intermediate visceral stent occlusion. The recent introduction of the Gore Balloon Expandable Viabahn VBX endoprosthesis offers a flexible alternative for stent graft placement into the visceral and iliac vessels during endovascular repair of complex aortic aneurysms.
Methods: A prospective institutional database was maintained for treatment of complex aortic aneurysms. Cases involving covered stent grafts placement into visceral vessels were selected during endovascular repair of juxtarenal and thoracoabdominal aortic aneurysms using fenestrated, branch, and parallel graft techniques from August 1, 2014, to December 31, 2017.
Results: A total of 179 patients underwent endovascular repair of complex aneurysms of which 102 patients had 231 stent grafts placed (41.3% VBX, 23.3% Atrium ICAST, and 35.3% Viabahn) into perivisceral segments (Table) . The mean age of patients was 75.0 years with 70.7% of patients male. There were 76 VBX and 155 other covered stent grafts placed into a renal artery (60.3% vs 66.7%) with a minority placed into the celiac artery (21.9% vs 14.5%) and superior mesenteric artery (17.8% vs 18.9%), respectively. The average number of stents used per vessel was 1.0 (VBX), 1.1 (ICAST), and 2.0 (Viabahn). The technical success of VBX deployment was 98.7% with a mean diameter of 6.4 mm. The primary patency of VBX was comparable with other covered stents (93.4% vs 96.1%; P ¼ .36) at a mean follow-up of 3.6 months. There were five VBX stent grafts which developed in-stent stenosis (one celiac) or occlusion (three renal; one superior mesenteric artery). One patient was asymptomatic and refused intervention. The remaining four stent grafts underwent intervention with 100% secondary patency. There was one gutter leak and no type III endoleaks at the fenestration site involving the VBX stent graft. These results are comparable with our experience using other stent graft technology in this setting except the Viabahn grafts required reinforcement with bare metal stents increasing the total number of stents required.
Conclusions: Our experience with the Gore Viabahn VBX endoprosthesis suggests that this new flexible technology is safe with a high technical success rate and promising short-term primary patency rate for use in visceral vessels requiring the fewest number of stents per vessel treated. The impact on long-term patency of flexible distal aspect of the stent will need further evaluation. 
